4,576 views
Video Summary: What Is Crispr Cas9 Genome Editing
Did you know that scientists can now edit DNA with the precision of a word processor? CRISPR CAS9 genome editing has revolutionized molecular biology by allowing researchers to cut, modify, and replace specific genes with unprecedented accuracy. This powerful technology, originally discovered as a bacterial immune system, is currently being tested in clinical trials at institutions like the University of Pennsylvania to treat sickle cell disease and cancer. Understanding what is CRISPR CAS9 genome editing opens doors to comprehending modern biotechnology and therapeutic development. Watch the full video on JoVE Coach to master this concept with expert-led visuals and step-by-step explanations.
CRISPR CAS9 genome editing represents one of the most significant breakthroughs in modern molecular biology. Originally evolved as a bacterial defense mechanism against viral infections, this system has been ingeniously repurposed to enable precise DNA modifications in virtually any organism. The acronym CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats, which describes the unique DNA sequences that bacteria use to store memories of past viral encounters.
The CRISPR CAS9 system operates through a sophisticated partnership between two main components. The Cas9 protein, derived from Streptococcus pyogenes, functions as programmable molecular scissors capable of cutting DNA at specific locations. The second component, a synthetic guide RNA (sgRNA), acts as a GPS system that directs Cas9 to the precise genomic target. This guide RNA must find a complementary DNA sequence adjacent to a Protospacer Adjacent Motif (PAM), typically a short NGG sequence that serves as a molecular landmark for Cas9 recognition.
CRISPR technology enables two primary types of genetic modifications that are frequently tested on AP Biology exams and college biochemistry courses. For gene insertion, researchers design a single sgRNA that guides Cas9 to create a double-strand break at the target site. The cell's natural repair machinery then incorporates a desired DNA sequence through homologous recombination, effectively installing new genetic information. Gene deletion requires a more complex approach using two sgRNAs that direct Cas9 to cut at both ends of the target region. The unwanted DNA segment is excised, and cellular repair systems join the remaining ends, permanently removing the targeted sequence.
The therapeutic potential of CRISPR CAS9 genome editing is being actively explored in numerous US clinical trials. Researchers at institutions like the National Institutes of Health and major medical centers are investigating treatments for sickle cell disease, beta-thalassemia, and certain cancers. One particularly promising application involves excising HIV DNA from infected T-cells, potentially offering a functional cure for AIDS patients. Advanced systems like Csy4 are being developed to target viral RNA molecules, expanding the toolkit beyond DNA editing to include RNA-based therapeutics.
Related Micro-courses